127 related articles for article (PubMed ID: 33723143)
1. Super-selective intra-arterial platinum-based chemotherapy concurrent with low-dose-rate plaque brachytherapy in the treatment of retinoblastoma: A simulation study.
Mostaghimi H; Ahmadabad FG; Rezaei H
J Cancer Res Ther; 2021; 17(1):130-135. PubMed ID: 33723143
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the shielding effectiveness of silicone oil vitreous substitutes when used with Palladium-103 and Iodine-125 eye plaques.
Yang YM; Chow PE; McCannel TA; Lamb JM
Med Phys; 2019 Feb; 46(2):1006-1011. PubMed ID: 30554429
[TBL] [Abstract][Full Text] [Related]
3. Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy.
Finger PT; Lu D; Buffa A; DeBlasio DS; Bosworth JL
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):849-54. PubMed ID: 8244814
[TBL] [Abstract][Full Text] [Related]
4. Measured, calculated, and egs_brachy I-125 dose distributions in a gold plaque for retinoblastoma treatment.
Trauernicht CJ; van Eeden D; du Plessis FCP
Med Phys; 2022 Sep; 49(9):6183-6194. PubMed ID: 35792659
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
Rezaei H; Zabihzadeh M; Ghorbani M; Goli Ahmadabad F; Mostaghimi H
Australas Phys Eng Sci Med; 2017 Sep; 40(3):545-553. PubMed ID: 28509080
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
DeMarco JJ; Hugo G; Solberg TD
Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
12. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
[TBL] [Abstract][Full Text] [Related]
13. Simulation study on potential accuracy gains from dual energy CT tissue segmentation for low-energy brachytherapy Monte Carlo dose calculations.
Landry G; Granton PV; Reniers B; Ollers MC; Beaulieu L; Wildberger JE; Verhaegen F
Phys Med Biol; 2011 Oct; 56(19):6257-78. PubMed ID: 21896967
[TBL] [Abstract][Full Text] [Related]
14. 103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design.
Rivard MJ; Reed JL; DeWerd LA
Med Phys; 2014 Jan; 41(1):011716. PubMed ID: 24387508
[TBL] [Abstract][Full Text] [Related]
15. Application of a directional palladium-103 brachytherapy device on a curved surface.
Veltchev I; Price R; Chen X; Howell K; Meyer J; Ma CM
Med Phys; 2019 Apr; 46(4):1905-1913. PubMed ID: 30734318
[TBL] [Abstract][Full Text] [Related]
16. Treatment of retinoblastoma vitreous base seeding.
Madreperla SA; Hungerford JL; Doughty D; Plowman PN; Kingston JE; Singh AD
Ophthalmology; 1998 Jan; 105(1):120-4. PubMed ID: 9442787
[TBL] [Abstract][Full Text] [Related]
17. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial Chemotherapy for Adult Onset Retinoblastoma in a 32-Year-Old Man.
Magan T; Khoo CT; Jabbour PM; Fuller DG; Shields CL
J Pediatr Ophthalmol Strabismus; 2016 Jul; 53():e43-6. PubMed ID: 27486894
[TBL] [Abstract][Full Text] [Related]
19. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
[TBL] [Abstract][Full Text] [Related]
20. Episcleral plaque brachytherapy for retinoblastoma.
Merchant TE; Gould CJ; Wilson MW; Hilton NE; Rodriguez-Galindo C; Haik BG
Pediatr Blood Cancer; 2004 Aug; 43(2):134-9. PubMed ID: 15236279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
